Brief: Theranexus To Present New Data On Medicine Candidate Thn102
05/07/2018 18:03
July 5 (Reuters) - THERANEXUS SA ALTHX.PA :
* TO PRESENT NEW DATA ON THE AWAKENING ACTIVITY OF HIS
MEDICINE
CANDIDATE THN102
* PRESENTATION WILL TAKE PLACE FROM THE 7TH TO THE 11TH JULY
IN
BERLIN
Source : https://bit.ly/2tYyPvb
Further company coverage: ALTHX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease